<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">vaccine </span>
   <span class="font28">development </span>
   <span class="font19">bottlenecks </span>
   <span class="font19">process </span>
   <span class="font19">vaccines </span>
   <span class="font18">tool </span>
   <span class="font16">clinical </span>
   <span class="font16">{border-style </span>
   <span class="font16">manufacturing </span>
   <span class="font16">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">outbreak </span>
   <span class="font15">development, </span>
   <span class="font14">Ebola </span>
   <span class="font14">animal </span>
   <span class="font14">appropriate </span>
   <span class="font14">research </span>
   <span class="font14">Vaccine </span>
   <span class="font14">potential </span>
   <span class="font14">trial </span>
   <span class="font14">discovery </span>
   <span class="font14">epidemic </span>
   <span class="font14">steps </span>
   <span class="font13">case </span>
   <span class="font13">early </span>
   <span class="font13">pathogen </span>
   <span class="font13">pre-clinical </span>
   <span class="font13">Phase </span>
   <span class="font13">[]. </span>
   <span class="font13">main </span>
   <span class="font13">platform </span>
   <span class="font13">studies </span>
   <span class="font13">UKVN </span>
   <span class="font13">candidate </span>
   <span class="font13">development. </span>
   <span class="font13">need </span>
   <span class="font13">work </span>
   <span class="font12">However, </span>
   <span class="font12">Pre-clinical </span>
   <span class="font12">candidates </span>
   <span class="font12">emerging </span>
   <span class="font12">ensure </span>
   <span class="font12">generic </span>
   <span class="font12">new </span>
   <span class="font12">overcome </span>
   <span class="font12">pathogens </span>
   <span class="font12">policy </span>
   <span class="font12">priority </span>
   <span class="font12">px; </span>
   <span class="font12">required </span>
   <span class="font12">use </span>
   <span class="font12">used </span>
   <span class="font12">{font-family </span>
   <span class="font12">GMP </span>
   <span class="font12">Regulatory </span>
   <span class="font12">better </span>
   <span class="font12">bottleneck </span>
   <span class="font12">challenge </span>
   <span class="font12">font-size </span>
   <span class="font12">funding </span>
   <span class="font12">global </span>
   <span class="font12">identified </span>
   <span class="font12">infectious </span>
   <span class="font12">limitations </span>
   <span class="font12">map </span>
   <span class="font12">model </span>
   <span class="font12">novel </span>
   <span class="font12">number </span>
   <span class="font12">sites </span>
   <span class="font12">stages </span>
   <span class="font12">viral </span>
   <span class="font12">(Fig. </span>
   <span class="font12">Development </span>
   <span class="font12">GMO </span>
   <span class="font12">TPP </span>
   <span class="font12">Zika </span>
   <span class="font12">address </span>
   <span class="font12">agreed </span>
   <span class="font12">based </span>
   <span class="font12">disease </span>
   <span class="font12">double; </span>
   <span class="font12">especially </span>
   <span class="font12">fill-finish </span>
   <span class="font12">future </span>
   <span class="font12">human </span>
   <span class="font12">identification </span>
   <span class="font12">international </span>
   <span class="font12">key </span>
   <span class="font12">licensure </span>
   <span class="font12">major </span>
   <span class="font12">mapping </span>
   <span class="font12">models </span>
   <span class="font12">nature </span>
   <span class="font12">regulations </span>
   <span class="font12">requires </span>
   <span class="font12">response </span>
   <span class="font12">testing </span>
   <span class="font12">using </span>
   <span class="font11">Clinical </span>
   <span class="font11">Elsevier </span>
   <span class="font11">Health </span>
   <span class="font11">R&amp;amp;D </span>
   <span class="font11">action </span>
   <span class="font11">antigen </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">capacity </span>
   <span class="font11">context </span>
   <span class="font11">corrective </span>
   <span class="font11">described </span>
   <span class="font11">develop </span>
   <span class="font11">different </span>
   <span class="font11">ethical </span>
   <span class="font11">facilities </span>
   <span class="font11">funders </span>
   <span class="font11">identify </span>
   <span class="font11">including </span>
   <span class="font11">investment </span>
   <span class="font11">limiting </span>
   <span class="font11">particularly </span>
   <span class="font11">possible </span>
   <span class="font11">regulatory </span>
   <span class="font11">require </span>
   <span class="font11">resource </span>
   <span class="font11">seen </span>
   <span class="font11">solid; </span>
   <span class="font11">taken </span>
   <span class="font11">technologies </span>
   <span class="font11">technology </span>
   <span class="font11">trials </span>
   <span class="font11">understand </span>
   <span class="font11">understanding </span>
   <span class="font11">vaccine, </span>
   <span class="font11">vaccines, </span>
   <span class="font11">vector </span>
   <span class="font11">virus </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">COVID- </span>
   <span class="font11">Fig. </span>
   <span class="font11">Plague </span>
   <span class="font11">Process </span>
   <span class="font11">Profile </span>
   <span class="font11">Research </span>
   <span class="font11">Target </span>
   <span class="font11">WG: </span>
   <span class="font11">bold </span>
   <span class="font11">cell </span>
   <span class="font11">centre </span>
   <span class="font11">challenges </span>
   <span class="font11">courier; </span>
   <span class="font11">current </span>
   <span class="font11">delays </span>
   <span class="font11">em; </span>
   <span class="font11">emergency </span>
   <span class="font11">engagement </span>
   <span class="font11">final </span>
   <span class="font11">government </span>
   <span class="font11">group </span>
   <span class="font11">importance </span>
   <span class="font11">information </span>
   <span class="font11">infrastructure </span>
   <span class="font11">interactive </span>
   <span class="font11">makers </span>
   <span class="font11">manufacture </span>
   <span class="font11">operate </span>
   <span class="font11">potentially </span>
   <span class="font11">preclinical </span>
   <span class="font11">process. </span>
   <span class="font11">product </span>
   <span class="font11">production </span>
   <span class="font11">pt;} </span>
   <span class="font11">public </span>
   <span class="font11">rate </span>
   <span class="font11">rate-limiting </span>
   <span class="font11">relevant </span>
   <span class="font11">safety </span>
   <span class="font11">separate </span>
   <span class="font11">significant </span>
   <span class="font11">stage </span>
   <span class="font11">study </span>
   <span class="font11">time </span>
   <span class="font11">trials. </span>
   <span class="font11">working </span>
   <span class="font11">workshops </span>
  </p>
 </body>
</html>
